title: Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells.
abstract: Cancer cells may survive under oxygen and nutrient deprivation by metabolic reprogramming for high levels of anaerobic glycolysis, which contributes to tumor growth and drug resistance. Abnormally expressed glucose transporters (GLUTs) are colocalized with hypoxia (Hx) inducible factor (HIF)1α in peri-necrotic regions in human colorectal carcinoma. However, the underlying mechanisms of anti-necrotic resistance conferred by glucose metabolism in hypoxic cancer cells remain poorly understood. Our aim was to investigate signaling pathways of Hx-induced necroptosis and explore the role of glucose pyruvate metabolite in mechanisms of death resistance. Human colorectal carcinoma cells were Hx exposed with or without glucose, and cell necroptosis was examined by receptor-interacting protein (RIP)1/3 kinase immunoprecipitation and (32)P kinase assays. Our results showed increased RIP1/3 complex formation and phosphorylation in hypoxic, but not normoxic cells in glucose-free media. Blocking RIP1 signaling, by necrostatin-1 or gene silencing, decreased lactodehydrogenase (LDH) leakage and plasma membrane disintegration. Generation of mitochondrial superoxide was noted after hypoxic challenge; its reduction by antioxidants inhibited RIP signaling and cell necrosis. Supplementation of glucose diminished the RIP-dependent LDH leakage and morphological damage in hypoxic cells, whereas non-metabolizable sugar analogs did not. Hypoxic cells given glucose showed nuclear translocation of HIF1α associated with upregulation of GLUT-1 and GLUT-4 expression, as well as increase of intracellular ATP, pyruvate and lactate levels. The glucose-mediated death resistance was ablated by iodoacetate (an inhibitor to glyceraldehyde-3-phosphate dehydrogenase), but not by UK5099 (an inhibitor to mitochondrial pyruvate carrier), suggesting that glycolytic pathway was involved in anti-necrotic mechanism. Lastly, replacing glucose with cell-permeable pyruvate derivative also led to decrease of Hx-induced necroptosis by suppression of mitochondrial superoxide in an energy-independent manner. In conclusion, glycolytic metabolism confers resistance to RIP-dependent necroptosis in hypoxic cancer cells partly through pyruvate scavenging of mitochondrial free radicals.
authors: Graduate Institute of Physiology, National Taiwan University College of Medicine, Taipei, Taiwan.
authors: C-Y
authors: CY
authors: Huang
authors: W-T
authors: WT
authors: Kuo
authors: Y-C
authors: YC
authors: Huang
authors: T-C
authors: TC
authors: Lee
authors: L C H
authors: LC
authors: Yu
mesh_terms: D017209:Apoptosis / Q000187:drug effects*; D018938:Caco-2 Cells; D015687:Cell Hypoxia; D015179:Colorectal Neoplasms / Q000378:metabolism / Q000473:pathology; D005947:Glucose / Q000494:pharmacology*; D051272:Glucose Transporter Type 1 / Q000235:genetics / Q000378:metabolism; D051275:Glucose Transporter Type 4 / Q000235:genetics / Q000378:metabolism; D006019:Glycolysis; D019073:HT29 Cells; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism; D007093:Imidazoles / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D008928:Mitochondria / Q000378:metabolism*; D009336:Necrosis; D028861:Nuclear Pore Complex Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D011773:Pyruvates / Q000378:metabolism*; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000378:metabolism; D016601:RNA-Binding Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D053422:Receptor-Interacting Protein Serine-Threonine Kinases / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D013481:Superoxides / Q000378:metabolism*
chemical_list: C119724:AGFG1 protein, human; D051272:Glucose Transporter Type 1; D051275:Glucose Transporter Type 4; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D007093:Imidazoles; D007211:Indoles; D028861:Nuclear Pore Complex Proteins; D011773:Pyruvates; D034741:RNA, Small Interfering; D016601:RNA-Binding Proteins; C507699:necrostatin-1; D013481:Superoxides; C119705:RIPK3 protein, human; D053422:Receptor-Interacting Protein Serine-Threonine Kinases; D005947:Glucose
references: Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8115-9
references: 7667254
references: Lab Invest. 2012 May;92(5):783-96
references: 22370946
references: FASEB J. 2005 Nov;19(13):1822-35
references: 16260652
references: Ann Anat. 2010 May 20;192(3):133-8
references: 20395120
references: Biochim Biophys Acta. 2005 Apr-May;1707(2-3):221-30
references: 15863100
references: Virchows Arch. 2008 May;452(5):535-44
references: 18351386
references: Cell Death Differ. 2009 Sep;16(9):1203-14
references: 19343039
references: Cancer Lett. 2000 Jun 30;154(2):137-42
references: 10806301
references: Science. 2001 Apr 20;292(5516):468-72
references: 11292861
references: Crit Care Med. 2011 Sep;39(9):2087-98
references: 21552122
references: Biochem J. 2004 Aug 1;381(Pt 3):761-7
references: 15104534
references: Cancer Lett. 2012 Oct 1;323(1):29-40
references: 22475682
references: Mini Rev Med Chem. 2009 Aug;9(9):1084-101
references: 19689405
references: Int J Parasitol. 2008 Jul;38(8-9):923-34
references: 18281046
references: Cell Death Differ. 2010 Oct;17(10):1540-50
references: 20339378
references: Cancer Res. 2006 Oct 15;66(20):9870-7
references: 17047048
references: Am J Physiol Cell Physiol. 2007 Jun;292(6):C2021-31
references: 17287367
references: Biochem Biophys Res Commun. 2011 Jan 14;404(2):695-700
references: 21156162
references: BMC Cancer. 2008 Nov 04;8:320
references: 18983642
references: Cancer Res. 2012 Jan 1;72(1):304-14
references: 22084398
references: Nature. 2011 Sep 14;477(7364):335-9
references: 21921917
references: Biochem Pharmacol. 2010 Jul 15;80(2):151-9
references: 20230800
references: J Biol Chem. 2006 Aug 18;281(33):23482-91
references: 16790428
references: Free Radic Biol Med. 2009 Jan 15;46(2):182-91
references: 19007879
references: Cancer Invest. 2008 Oct;26(8):852-9
references: 18853313
references: Cell. 2009 Jul 23;138(2):229-32
references: 19632174
references: J Immunol. 2007 Oct 15;179(8):4953-7
references: 17911579
references: Med Oncol. 2011 Dec;28 Suppl 1:S197-203
references: 21080109
references: J Transl Med. 2011 Feb 08;9:19
references: 21303518
references: J Endocrinol. 2004 Oct;183(1):145-54
references: 15525582
references: Endocr Relat Cancer. 2010 May 18;17(2):539-51
references: 20356977
references: Nat Rev Clin Oncol. 2012 Apr 24;9(7):378-90
references: 22525710
references: J Immunol. 2006 Sep 1;177(5):3273-82
references: 16920968
references: Cell. 2009 Jun 12;137(6):1100-11
references: 19524512
references: Cancer Res. 2005 Sep 15;65(18):8134-41
references: 16166287
references: Am J Physiol. 1997 Oct;273(4):G968-78
references: 9357843
references: J Cell Physiol. 2006 Jun;207(3):614-27
references: 16523487
references: J Exp Med. 2012 Feb 13;209(2):211-5
references: 22330683
references: Neurosci Lett. 1998 Jan 2;240(1):21-4
references: 9488165
references: Am J Respir Cell Mol Biol. 1999 Dec;21(6):710-8
references: 10572068
references: Clinics (Sao Paulo). 2007 Jun;62(3):315-20
references: 17589673
references: Odontology. 2012 Jul;100(2):156-63
references: 21607591
references: Cancer Res. 2002 Nov 15;62(22):6674-81
references: 12438266
references: Cell. 2009 Jun 12;137(6):1112-23
references: 19524513
references: World J Gastroenterol. 2005 Sep 21;11(35):5485-91
references: 16222741
references: J Physiol. 2003 Oct 15;552(Pt 2):335-44
references: 14561818
references: Am J Physiol. 1999 Dec;277(6):H2240-6
references: 10600842
references: Gut. 2012 Jun;61(6):855-64
references: 21890811
references: Science. 2009 Jul 17;325(5938):332-6
references: 19498109
references: Nature. 2011 Jul 31;477(7364):330-4
references: 21804564
references: Lab Invest. 2011 Feb;91(2):294-309
references: 20975661
references: Hepatogastroenterology. 2010 Jul-Aug;57(101):741-5
references: 21033220
references: Science. 2012 Jul 6;337(6090):93-6
references: 22628554
references: Nat Rev Cancer. 2008 Sep;8(9):705-13
references: 19143055
references: JPEN J Parenter Enteral Nutr. 2002 Mar-Apr;26(2):71-6
references: 11871739
references: Cancer Res. 2005 Jan 15;65(2):613-21
references: 15695406
references: Mol Cell Biol. 2006 Mar;26(6):2215-25
references: 16507998
references: J Pediatr Surg. 2012 Jul;47(7):1323-30
references: 22813791